Aurobindo Pharma to Participate in Kotak Healthcare Forum 2026
Aurobindo Pharma Ltd 路 Intimation 路 11 Sept 2026, 6:46 pm
Aurobindo Pharma to Participate in Kotak Healthcare Forum 2026 Aurobindo Pharma Limited announced that company officials will participate in the Kotak Healthcare Forum 2026 on 18th Sep'26 in Mumbai from 09:00 AM to 05:00 PM IST. The engagement will feature both one-on-one and group investor/analyst meetings. The company confirmed that no unpublished price sensitive information (UPSI) will be discussed during the interactions, and the schedule remains subject to changes based on exigencies.
Original exchange filing (PDF)
More announcements from Aurobindo Pharma Ltd
- Intimation of classification of US FDA inspection at Lannet Company LLC, a wholly owned subsidiary of Aurobindo Pharma USA Inc., a wholly owned subsidiary of the Company. 路 12 Nov 2026
- Submission of Earning Call Transcript for Q2FY27. 路 11 Nov 2026
- Unit-2 of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company received Establishment Inspection Report from US FDA with classification as "Voluntary Action Indicated". 路 11 Nov 2026
- Intimation of investors / analysts meet to be held on 17.11.2026. 路 09 Nov 2026
- Intimation of investor / analysts meet to be held on 16.09.2026. 路 09 Nov 2026
- Submission of Financial results for the Quarter and Half year ended September 30, 2026. 路 05 Nov 2026
- Reappointment of Mr. M. R. Kumar as Independent Director of the Company for second term with effect from April 1, 2027. 路 05 Nov 2026
- Transfer of ownership of Auro Pharma LLC, Russia from Auroactive Pharma Private Limited to Auropharm Overseas Limited, Wholly Owned subsidiaries of the Company. 路 05 Nov 2026
